Literature DB >> 12399051

Intraductal papillary mucinous neoplasms of the pancreas: pathology and molecular genetics.

N Volkan Adsay1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12399051     DOI： 10.1016/s1091-255x(02)00057-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  20 in total

1.  p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.

Authors:  C A Moskaluk; R H Hruban; S E Kern
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

2.  Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors.

Authors:  G Zamboni; A Scarpa; G Bogina; C Iacono; C Bassi; G Talamini; F Sessa; C Capella; E Solcia; F Rickaert; G M Mariuzzi; G Klöppel
Journal:  Am J Surg Pathol       Date:  1999-04       Impact factor: 6.394

3.  Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.

Authors:  C A Iacobuzio-Donahue; D S Klimstra; N V Adsay; R E Wilentz; P Argani; T A Sohn; C J Yeo; J L Cameron; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

Review 4.  Genetics of pancreatic cancer. From genes to families.

Authors:  R H Hruban; G M Petersen; P K Ha; S E Kern
Journal:  Surg Oncol Clin N Am       Date:  1998-01       Impact factor: 3.495

5.  Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas.

Authors:  K Z'graggen; J A Rivera; C C Compton; M Pins; J Werner; C Fernández-del Castillo; D W Rattner; K B Lewandrowski; A K Rustgi; A L Warshaw
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

6.  Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management.

Authors:  M Kobari; S Egawa; K Shibuya; H Shimamura; M Sunamura; K Takeda; S Matsuno; T Furukawa
Journal:  Arch Surg       Date:  1999-10

Review 7.  Expression of mucin antigens in human cancers and its relationship with malignancy potential.

Authors:  S Yonezawa; E Sato
Journal:  Pathol Int       Date:  1997-12       Impact factor: 2.534

8.  Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.

Authors:  R H Hruban; N V Adsay; J Albores-Saavedra; C Compton; E S Garrett; S N Goodman; S E Kern; D S Klimstra; G Klöppel; D S Longnecker; J Lüttges; G J Offerhaus
Journal:  Am J Surg Pathol       Date:  2001-05       Impact factor: 6.394

9.  Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.

Authors:  F Sessa; E Solcia; C Capella; M Bonato; A Scarpa; G Zamboni; N S Pellegata; G N Ranzani; F Rickaert; G Klöppel
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Chromosome abnormalities in pancreatic adenocarcinoma.

Authors:  C A Griffin; R H Hruban; P P Long; L A Morsberger; F Douna-Issa; C J Yeo
Journal:  Genes Chromosomes Cancer       Date:  1994-02       Impact factor: 5.006
View more
  6 in total

Review 1.  [Duodenum-preserving total pancreatic head resection : an organ-sparing operation technique for cystic neoplasms and non-invasive malignant tumors].

Authors:  H G Beger; M Siech; B Poch
Journal:  Chirurg       Date:  2013-05       Impact factor: 0.955

Review 2.  Pancreatic intraductal papillary mucinous neoplasm with concomitant heterotopic pancreatic cystic neoplasia of the stomach: a case report and review of the literature.

Authors:  Dimitrios Tsapralis; Alexandros Charalabopoulos; Eva Karamitopoulou; Dimitrios Schizas; Konstantinos Charalabopoulos; Theodoros Liakakos; Anastasios Macheras
Journal:  Diagn Pathol       Date:  2010-01-14       Impact factor: 2.644

Review 3.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

Review 4.  Pancreatic cystic neoplasms: a review of preoperative diagnosis and management.

Authors:  Xue-li Bai; Qi Zhang; Noman Masood; Waqas Masood; Yun Zhang; Ting-bo Liang
Journal:  J Zhejiang Univ Sci B       Date:  2013-03       Impact factor: 3.066

5.  Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Norihiro Sato; Noriyoshi Fukushima; Anirban Maitra; Christine A Iacobuzio-Donahue; N Tjarda van Heek; John L Cameron; Charles J Yeo; Ralph H Hruban; Michael Goggins
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

6.  Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms.

Authors:  Kazuhiro Yoshida; Takeshi Nagasaka; Yuzo Umeda; Takehiro Tanaka; Keisuke Kimura; Fumitaka Taniguchi; Tomokazu Fuji; Kunitoshi Shigeyasu; Yoshiko Mori; Hiroyuki Yanai; Takahito Yagi; Ajay Goel; Toshiyoshi Fujiwara
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-19       Impact factor: 4.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.